PANACEA COOPERATIVE RESEARCH S COOP

Their core work

Panacea is a Spanish research cooperative that applies artificial intelligence and machine learning to forensic identification problems — specifically, automating the analysis of skeletal and radiological data to determine biological profiles (age, sex, ancestry) from human remains or living individuals. Their work sits at the intersection of forensic anthropology, medical imaging, and AI, translating what was previously a labor-intensive expert judgment into software-driven workflows. They have pursued two concrete application domains: AI-assisted skeletal identification for law enforcement or disaster victim identification (SKELETONID), and automated forensic age estimation for unaccompanied minors in legal proceedings (UMAFAE). Despite being a small cooperative, they operate as project coordinators and research drivers rather than service subcontractors.

What they specialise in

How they've shifted over time

Their first project, SKELETONID (2019), was a Phase 1 SME Instrument feasibility study — broad in scope, positioning AI as a tool for physical anthropology and human identification without yet specifying a clinical or legal channel. By 2022, with UMAFAE, the focus had narrowed sharply: forensic radiology, machine learning, and biological profile estimation applied to a specific legal population — unaccompanied minors in asylum proceedings. The shift is from a general proof-of-concept (can AI read skeletons?) to a deployable forensic tool with a defined legal use case and a specific patient/subject group.

Panacea is narrowing from broad forensic AI toward production-ready tools for legally sensitive identification tasks — a direction that points toward public-sector procurement, law enforcement, and immigration/asylum systems as their likely commercial targets.

How they like to work

Panacea has coordinated both of their H2020 projects independently, with no consortium partners recorded in the data — consistent with SME Instrument Phase 1 (solo applicant) and MSCA Individual Fellowship (single host institution) grant structures, neither of which requires a multi-partner consortium. This suggests they build expertise through researcher mobility and solo grant leadership rather than broad partnership networks. Organizations considering working with Panacea should expect them as a specialist host or technical lead, not as a networked consortium hub.

No consortium partners are recorded across their two H2020 projects, which reflects the grant types used (SME-1 and MSCA-IF) rather than necessarily indicating isolation. Their MSCA-IF participation signals they have attracted and hosted individual researchers, suggesting informal scientific networks that do not appear in CORDIS partner counts.

What sets them apart

Panacea occupies a rare niche: a small cooperative that treats forensic anthropology as a technology problem, building AI tools where the output feeds directly into legal and humanitarian decisions. Most forensic AI work in Europe comes from large university hospitals or law enforcement labs — Panacea's cooperative structure and SME status give them faster development cycles and commercial flexibility that academic groups lack. Their UMAFAE project on age estimation for unaccompanied minors specifically addresses a documented gap in EU asylum systems, giving them a policy-relevant application with real procurement potential.

Highlights from their portfolio

• UMAFAE
  Their most developed and best-funded project (EUR 172,932), combining forensic radiology, machine learning, and biological profile estimation for a legally sensitive application — automated age assessment of unaccompanied minors — with direct relevance to EU asylum and border management systems.
• SKELETONID
  An SME Instrument Phase 1 feasibility grant positioning AI-assisted skeletal identification as a commercial product, demonstrating early intent to build a forensic technology business rather than purely academic research outputs.